What Will It Take for Sanofi to Snag Medivation? $63 a Share
June 02, 2016 at 13:30 PM EDT
If Sanofi (SNY) wants to buy Medivation (MDVN), it is going to have to up its bid for the cancer drug maker, perhaps to $63 a share. And that move could open the flood gates to rival offers for the cancer drug maker. Or so says Credit Suisse analyst Kennen MacKay, in a note published […]
